Cargando…

A novel validated assay to support the discovery of new anti-malarial gametocytocidal agents

BACKGROUND: Drugs that kill or inhibit Plasmodium gametocytes in the human host could potentially synergize the impact of other chemotherapeutic interventions by blocking transmission. To develop such agents, reliable methods are needed to study the in vitro activity of compounds against gametocytes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bahamontes-Rosa, Noemí, Gomez-Lorenzo, María G., Lelièvre, Joël, Rodriguez Alejandre, Ane, Almela, María Jesus, Lozano, Sonia, Herreros, Esperanza, Gamo, Francisco-Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957904/ https://www.ncbi.nlm.nih.gov/pubmed/27448565 http://dx.doi.org/10.1186/s12936-016-1429-9

Ejemplares similares

New molecular settings to support in vivo anti-malarial assays
por: Bahamontes-Rosa, Noemí, et al.
Publicado: (2016)

Activity of Clinically Relevant Antimalarial Drugs on Plasmodium falciparum Mature Gametocytes in an ATP Bioluminescence “Transmission Blocking” Assay
por: Lelièvre, Joël, et al.
Publicado: (2012)

Activity of clinically relevant antimalarial drugs on Plasmodium falciparum mature gametocytes in an ATP bioluminescence “transmission blocking” assay
por: Lelièvre, Joël, et al.
Publicado: (2012)

A New Set of Chemical Starting Points with Plasmodium falciparum Transmission-Blocking Potential for Antimalarial Drug Discovery
por: Almela, Maria Jesus, et al.
Publicado: (2015)

In vitro anti-malarial interaction and gametocytocidal activity of cryptolepine
por: Forkuo, Arnold Donkor, et al.
Publicado: (2017)

Isoliensinine from Cissampelos pariera rhizomes exhibits potential gametocytocidal and anti-malarial activities against Plasmodium falciparum clinical isolates
por: Muema, Jackson M., et al.
Publicado: (2023)

Mechanistic Modeling of Primaquine Pharmacokinetics, Gametocytocidal Activity, and Mosquito Infectivity
por: Chotsiri, Palang, et al.
Publicado: (2022)

Red blood cells derived from peripheral blood and bone marrow CD34+ human haematopoietic stem cells are permissive to Plasmodium parasites infection
por: Fernandez-Becerra, Carmen, et al.
Publicado: (2013)

Chemical signatures and new drug targets for gametocytocidal drug development
por: Sun, Wei, et al.
Publicado: (2014)

Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malaria
por: White, Nicholas J, et al.
Publicado: (2014)

Identifying rapidly parasiticidal anti-malarial drugs using a simple and reliable in vitro parasite viability fast assay
por: Linares, María, et al.
Publicado: (2015)

Functional screening of selective mitochondrial inhibitors of Plasmodium
por: Gomez-Lorenzo, Maria G., et al.
Publicado: (2018)

Anti-malarial activity of the alkaloid, heptaphylline, and the furanocoumarin, imperatorin, from Clausena anisata against human Plasmodium falciparum malaria parasites: ex vivo trophozoitocidal, schizonticidal and gametocytocidal approach
por: Kumatia, Emmanuel Kofi, et al.
Publicado: (2023)

Bioassay-guided isolation and identification of gametocytocidal compounds from Artemisia afra (Asteraceae)
por: Moyo, Phanankosi, et al.
Publicado: (2019)

Streamlined and Robust Stage-Specific Profiling of Gametocytocidal Compounds Against Plasmodium falciparum
por: Reader, Janette, et al.
Publicado: (2022)

Predicting transmission blocking potential of anti-malarial compounds in the Mosquito Feeding Assay using Plasmodium falciparum Male Gamete Inhibition Assay
por: Colmenarejo, Gonzalo, et al.
Publicado: (2018)

Editorial Commentary: Single-Dose Primaquine as Gametocytocidal Treatment in Patients With Uncomplicated Falciparum Malaria
por: Dondorp, Arjen M.
Publicado: (2013)

Gametocytocidal Screen Identifies Novel Chemical Classes with Plasmodium falciparum Transmission Blocking Activity
por: Sanders, Natalie G., et al.
Publicado: (2014)

Differential activity of novel gametocytocidal compounds: drug mode-of-action and ex vivo efficacy
por: Birkholtz, Lyn-Marie, et al.
Publicado: (2014)

Blocking Plasmodium falciparum Malaria Transmission with Drugs: The Gametocytocidal and Sporontocidal Properties of Current and Prospective Antimalarials
por: Kiszewski, Anthony E.
Publicado: (2010)

Injectable anti-malarials revisited: discovery and development of new agents to protect against malaria
por: Macintyre, Fiona, et al.
Publicado: (2018)

Gametocytes from K13 Propeller Mutant Plasmodium falciparum Clinical Isolates Demonstrate Reduced Susceptibility to Dihydroartemisinin in the Male Gamete Exflagellation Inhibition Assay
por: Lozano, Sonia, et al.
Publicado: (2018)

CYP2D6 Polymorphisms and the Safety and Gametocytocidal Activity of Single-Dose Primaquine for Plasmodium falciparum
por: Pett, Helmi, et al.
Publicado: (2019)

Strong Gametocytocidal Effect of Methylene Blue-Based Combination Therapy against Falciparum Malaria: A Randomised Controlled Trial
por: Coulibaly, Boubacar, et al.
Publicado: (2009)

Novel Highlight in Malarial Drug Discovery: Aspartate Transcarbamoylase
por: Wang, Chao, et al.
Publicado: (2022)

Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs
por: Bousema, Teun, et al.
Publicado: (2010)

The Gametocytocidal Efficacy of Different Single Doses of Primaquine with Dihydroartemisinin-piperaquine in Asymptomatic Parasite Carriers in The Gambia: A Randomized Controlled Trial()
por: Okebe, Joseph, et al.
Publicado: (2016)

Safety of single-dose primaquine as a Plasmodium falciparum gametocytocide: a systematic review and meta-analysis of individual patient data
por: Stepniewska, Kasia, et al.
Publicado: (2022)

Use of belimumab in real-world in Spain: a scoping review about characteristics of SLE patients
por: Escalera, Carlos Rodríguez, et al.
Publicado: (2022)

An in vitro toolbox to accelerate anti-malarial drug discovery and development
por: Charman, Susan A., et al.
Publicado: (2020)

A randomized, parallel study of the safety and efficacy of 45 mg primaquine versus 75 mg bulaquine as gametocytocidal agents in adults with blood schizonticide-responsive uncomplicated falciparum malaria [ISCRTN50134587]
por: Gogtay, NJ, et al.
Publicado: (2006)

Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common
por: White, Nicholas J, et al.
Publicado: (2012)

An assessment of the supply, programmatic use, and regulatory issues of single low-dose primaquine as a Plasmodium falciparum gametocytocide for sub-Saharan Africa
por: Chen, Ingrid, et al.
Publicado: (2015)

The gametocytocidal efficacy of primaquine in malaria asymptomatic carriers treated with dihydroartemisinin-piperaquine in The Gambia (PRINOGAM): study protocol for a randomised controlled trial
por: Okebe, Joseph, et al.
Publicado: (2015)

Novel lead structures with both Plasmodium falciparum gametocytocidal and asexual blood stage activity identified from high throughput compound screening
por: Sun, Wei, et al.
Publicado: (2017)

Evaluation of bioluminescence-based assays of anti-malarial drug activity
por: Hasenkamp, Sandra, et al.
Publicado: (2013)

Assessing anti-malarial drug effects ex vivo using the haemozoin detection assay
por: Rebelo, Maria, et al.
Publicado: (2015)

Is "Malarial Cachexia" Purely Malarial?
por: Rogers, Leonard
Publicado: (1902)

Malarial Fevers and Malarial Parasites
Publicado: (1903)

Pharmacopeial quality of artemether–lumefantrine anti-malarial agents in Uganda
por: Ocan, Moses, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_340rebob3ofa9pp4aeijionb2e